It is becoming clear that MAO-A overexpression is associated with prostate cellular dedifferentiation, tumorigenesis, aggressiveness, metastasis, as well as depressive symptoms, which dictate its inhibition, for potential PCa treatment and depression management. This evidence concerns the gene MAOA and major depressive disorder.